Ondacap

Ondacap

ondansetron

Manufacturer:

Sanbe

Marketer:

Caprifarmindo
Concise Prescribing Info
Contents
Ondansetron
Indications/Uses
Management of nausea & vomiting induced by chemotherapy, radiotherapy & op.
Dosage/Direction for Use
Treatment of post-op nausea & vomiting 4 mg single dose by IM or slow IV inj. Prevention of nausea & vomiting associated w/ chemotherapy & radiotherapy Highly emetogenic chemotherapy eg, cisplatin: Initially 8 mg slow IV or infusion for 15 min immediately prior to chemotherapy, followed by ondansetron 1 mg/hr continuous infusion for <24 hr or 2 inj of 8 mg by slow IV or infusion for 15 min w/ 4 hr interval. Also could be followed by 8 mg orally twice daily for <5 days. Moderately emetogenic chemotherapy eg, cyclosphamide: 8 mg by slow IV inj or infusion for 15 min immediately prior to chemotherapy, followed by 8 mg orally twice daily for <5 days. Childn >4 yr 5 mg/m2 IV over 15 min immediately prior to chemotherapy, followed by 4 mg orally every 12 hr for up to 5 days. Patient w/ impaired hepatic function Max: 8 mg.
Contraindications
Special Precautions
Adverse Reactions
Headache, flushing or warmth sensation in the head & epigastrum, sedation, constipation & diarrhea.
Drug Interactions
CYP450 inducers & inhibitors.
ATC Classification
A04AA01 - ondansetron ; Belongs to the class of serotonin (5HT3) antagonists. Used for the prevention of nausea and vomiting.
Presentation/Packing
Form
Ondacap inj 2 mg/mL
Packing/Price
2 mL x 5 × 1's (Rp125,000/boks);4 mL x 5 × 1's (Rp200,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in